Featured Speakers

Name BIO
Dr. Eric Goralnick

Eric Goralnick, MD graduated from the United States Naval Academy in 1995. He served as a Surface Warfare Officer in the United States Navy and completed multiple overseas deployments. After shadowing Navy Physicians and Corpsmen overseas, he attended the Sackler School of Medicine at Tel Aviv University and then completed his residency training in Emergency Medicine at Yale-New Haven Hospital, serving as Chief Resident during his final year.

Goralnick now serves as Medical Director of Emergency Preparedness and Associate Clinical Director of the Emergency Department at Brigham and Women’s Hospital, a 792 quaternary care academic teaching affiliate of Harvard Medical School located in Boston, Massachusetts.  He also provides medical direction for all concerts and New England Patriots’ football games at Gillette Stadium.

Goralnick is also a Senior Associate at the National Preparedness Leadership Initiative (NPLI), a joint venture of the Harvard School of Public Health’s Division of Policy Translation and Leadership Development and the Harvard Kennedy School’s Center for Public Leadership focused on the study of crisis leadership.

Goralnick has lectured nationally and internationally on Emergency Preparedness.  Goralnick was among those who responded in the immediate aftermath of the Boston Marathon bombings and with NPLI, has facilitated several debriefs and interviews of key personnel involved in the response. 

2014 Presentation - Fight

2014 Presentation - Results

Dr. Andre Denault

Anesthesiologist and Critical Care Physician
Centre Hospitalier de l’Université de Montréal
Hôpital Notre-Dame (Active member/Associate member)
Montreal Heart Institute Anesthesiologist (Active member)
Clinical scientist, Junior 1 FRSQ
Clinical scientist, Junior 2 FRSQ
Clinical scientist, Sénior FRSQ
MD, Université de Montréal 82/09 to 87/05
Internal medicine, McGill University 87/07 to 91/06
Critical Care fellowship, Presbyterian-University Hospital, Pittsburgh 91/07 to 93/06
Anesthesiology, Université de Montréal 93/07 to 95/12
Re-Certification in Perioperative Transesophageal Echocardiography National Board of Echocardiography 2010
PhD in biomedical science, University of Montreal 2010
Articles: 110 peer-reviewed articles
Book : 2 textbook (TEE Multimedia Manual, 2nd édition in 2010), 19 articles non peer-reviewed, 26 book chapters
Abstracts: 226 (57 published et 169 presented)
Conferences : 240
Teaching award (1996-2011): 14

Dr. Laurance Lequier

Dr. Laurance Lequier is a Pediatric Intensivist and Director of the Extracorporeal Life Support Program, at the Stollery Children’s Hospital in Edmonton, Alberta, Canada. His research interests include neurologic outcomes following extracorporeal membrane oxygenation (ECMO) and the anticoagulation of extracorporeal circuits. Dr. Lequier has been a steering committee member of the international Extracorporeal Life Support Organization (ELSO) for the past 5 years and is the chair of ELSO’s task force on ECMO Anticoagulation. Dr. Lequier is very involved with ECMO education and simulation and has spoken extensively on these topics throughout North and South America.

2014 Presentation

Dr. Paul Mohapel

Paul Mohapel began his career as a neuroscientist, and while working in Sweden he had an epiphany that inspired him to leave science and move towards leadership. Today, he uses his knowledge of the brain, psychology and leadership to consult, facilitate and educate with organizations. Mohapel believes that effective leadership requires a holistic approach that requires emotional, spiritual, social and systemic thinking skills. His research interests include the biological and social underpinnings of leadership. Both, as an educator and a facilitator, he takes this holistic approach so that learners can connect more deeply with the content.


Mohapel works with a wide array of clients, ranging from private corporations to health care, to build greater leadership capacity. He has taught at the postgraduate level for 17 years. In addition to teaching at Royal Roads, Mohapel is a faculty for the Canadian Medical Association, both designing and facilitating workshops for physicians. His areas of expertise include emotional intelligence, mindfulness, engagement, interpersonal communication, team processes, talent management, strength-based leadership, and curriculum and research design.


Mohapel holds a PhD in psychology from the University of Victoria and a Master’s in Leadership and Training from Royal Roads University. He also holds a master’s of science and a bachelor of science in psychology from Carleton University. He is a certified facilitator in the following: Bar-On EQ-I; Myers-Briggs Type Indicator; Insights Discovery; Instructional Skills Workshop; Problem-Based Learning; and Team Building. He has won the following awards: European Union Operating Research Grant ($800,000); Lund Foundation Research Award ($50,000); NSERC Postdoctoral Fellowship ($70,000); and Ontario Graduate Teaching Fellowship ($12,000).

Dr. George G. Zhanel

- Professor, Departmental of Medical Microbiology, University of Manitoba
- Director, Canadian Antimicrobial Resistance Alliance
- Ph.D. Medical Microbiology (University of Manitoba, 1994),
- Doctor of Pharmacy (University of Minnesota, 1986)
Teaching Interests:
Prevention and treatment of infectious diseases. 25 years teaching experience to specialists, general practitioners and students in medicine, nursing, pharmacy, biomedical sciences and lab technology.
Over 40 teaching awards/nominations
Recent Publications: (selected from 800+)
1. Baseline epidemiology of Streptococcus pneumoniae
2. next generation aminoglycoside.
3. Ceftaroline pharmacodynamic activity
4. Antibacterial activities of aminoglycoside.
5. Prevalence of antimicrobial resistant pathogens in Canadian hospitals

Presented over 800 lectures as an invited speaker at international, national, and local meetings speaking on the topics of prevention and treatment of infectious diseases in Canada, United States, Central America, Western and Eastern Europe including Russia, Australia, Southern and Northern Africa, the Middle East and Asia.Recent Patents: Six patents on novel agents with antimicrobial activity. 

2014 Presentation - ICU

2014 Presentation - C-DiffTX

Dr. Derek Angus

Dr. Angus is Professor and Chair of the Department of Critical Care Medicine and Director of CRISMA (Clinical Research, Investigation, and Systems Modeling of Acute Illnesses) Center at the University of Pittsburgh. He holds secondary appointments in Medicine, Health Policy and Management, and Clinical and Translational Science. He trained at the University of Glasgow and University of Pittsburgh and spent a year in Hong Kong with Medicins Sans Frontieres.
Dr. Angus’ research interest includes clinical, epidemiologic and translational studies of sepsis, pneumonia, and multi-system organ failure, as well as health services research of the organization and delivery of critical care services. He is the founder and director of the CRISMA Center, which is comprised of adult and pediatric critical care physicians and dedicated research staff who specialize in clinical and health services research of the acutely ill. This large team of clinicians, mathematicians, and epidemiologists enjoys superb funding from the NIH and multiple industrial sponsors, and is regarded by many as one of the world’s foremost translational research groups. Their publications appear in leading journals such as the New England Journal of Medicine, JAMA, Lancet, Critical Care Medicine, and the American Journal of Respiratory and Critical Care Medicine.
Dr. Angus has published several hundred papers, reviews, and book chapters, is currently section editor for “Caring for the Critically Ill” for JAMA. He is the recipient of numerous awards, including the 2009 American College of Critical Care Medicine Distinguished Investigator Award, the 2011 Master Critical Care Medicine and Presidential Citation, Society of Critical Care Medicine.

Dr. Simon Finfer

Simon Finfer is a Senior Staff Specialist in Intensive Care at Royal North Shore Hospital in Sydney and a Director of the Critical Care and Trauma Division of The George Institute for International Health. He is a Professor in the Faculty of Medicine of the University of Sydney and Honorary Associate Professor in the Department of Epidemiology and Preventative Medicine at Monash University in Melbourne. He is a past-Chair of the Australian and New Zealand Intensive Care Society Clinical Trials Group and a member of the Governing Board for the Australian and New Zealand Intensive Care Research Centre in Melbourne. His postgraduate qualifications include Fellowship of the Royal Colleges of Physicians of the United Kingdom, Fellowship of the Royal College of Anaesthetists of the United Kingdom and Fellowship of the Joint Faculty of Intensive Care Medicine of the Royal Australasian College of Physicians and Australian and New Zealand College of Anaesthetists.
Professor Finfer's major academic interest is the design and conduct of large scale randomised controlled trials in critical care. He was the lead investigator for the 6997 patient SAFE study (N Engl J Med 2004 May 27;350:2247-56) and is the lead investigator and study Chair for the 6100 patient NICE-SUGAR study.
Competing interests statement:
Professor Finfer has received research funding and travel support from CSL Bioplasma and Eli Lilly. Professor Finfer is a member of the steering committees for the PROWESS-SHOCK Trial (Lilly) and the ACCESS Trial (Eisai Ltd.).

Professor Finfer does not accept payments from pharmaceutical companies, all honoraria and consulting fees are paid to his employing institutions’ research funds.

2014 Presentation

Dr. Doug Brown

Doug Brown is an Emergency physician at Royal Columbian Hospital, he is a BC mountain rescue technician, a member of the international commission for mountain emergency medicine as well as a ski doctor for Whistler Blackcomb and Mike Wiegele's helicopter skiing. He has a particular interest in wilderness and environmental emergencies, and was the lead author on a review of accidental hypothermia published in the November 15, 2012 issue of the New England Journal of Medicine.

2014 Presentation

Dr. Michael Ramsay

Dr. Ramsay serves as President of Baylor Research Institute (BRI) and is Chief of Service for the Department of Anesthesiology and Pain Management at Baylor University Medical Center in Dallas, Texas.  He is the developer of the most widely used sedation scoring system in anesthesiology that is used in critical care units world-wide, the Ramsay Sedation Scale.  Dr. Ramsay has authored more than 128 peer-reviewed manuscripts and is an invited speaker at national and international scientific meetings.  Dr. Ramsay attended London Hospital Medical College at London University.  He joined Baylor in 1976 and was appointed chief of anesthesiology in 1989.  He is the Co-Medical Director of Operating Room Services and is a member of the Board of Trustees of Baylor University Medical Center in Dallas, Texas.

2014 Presentation 1

2014 Presentation 2

Dr. Mervyn Singer

Mervyn Singer is Professor of Intensive Care Medicine at University College London, UK. He is a UK National Institute of Health Senior Investigator and his research interests include sepsis, multi-organ failure, shock states, tissue oxygenation and haemodynamic monitoring. He's developed a few monitoring devices and is currently working on a few novel drugs.  He has also written/edited various critical care textbooks.

Dr. Ian Rigby

Ian is an emergency physician in Calgary. He completed his medical school in Calgary and his Royal College residency in emergency medicine at Queen's University in 2002 where he worked for a year before returning west. Ian's academic interest area is medical education. He has had the good fortune of co-creating and chairing the undergraduate procedural skills program at University Calgary as well as being a cofounder of the Hemodynamic Instability Course, which had been run throughout Canada and the US. Ian also has had the opportunity to develop and run Calgary's interdisciplinary emergency medicine simulation program for a number of years before becoming the program director in emergency medicine at the University of Calgary. He was shocked and delighted to be asked to speak at this year's conference.

2014 Presentation

Dr. Christopher...

Doctor Farmer is Professor and Chair, Department of Critical Care Medicine, Mayo Clinic Arizona. He previously served at Mayo Clinic in Rochester, Minnesota as critical care medicine fellowship program director; Associate Dean, Mayo School of Graduate Medical Education; and, Associate Chair for Education, Department of Medicine. Doctor Farmer is the currently President elect, Society of Critical Care Medicine, and will be President during 2014. He is editor and author of numerous books related to critical care, education, and disaster medical response.

Doctor Farmer is a retired Air Force Colonel and Professor of Medicine and Surgery, Uniformed Services University of the Health Sciences, F. Edward Hébert School of Medicine. He is one of the founders of the Department of Defense Critical Care Aeromedical Transport Team (CCATT) program. As a senior physician executive, Doctor Farmer served as Chief of Inpatient Services at Wilford Hall Medical Center, Chief Medical Officer for TRICARE Southwest, and Special Assistant to the Air Force Surgeon General for Homeland Defense and Medical Preparedness.

2014 Presentation

Dr. Jessica Mac...

Jessica MacKenzie-Feder studied medicine at McGill University and completed both internal medicine and endocrinology at the University of British Columbia. She pursued a subspecialty in pituitary and adrenal disorders at the University of Montreal and is a new member of the Division of Endocrinology and Metabolism at UBC based at St Paul's Hospital. Her clinical and research interest is in Cushing's disease.

2014 Presentation

Dr. Donald Griesdale

Dr. Donald Griesdale is an intensive care physician and anesthesiologist at Vancouver General Hospital and Assistant Professor in the Department of Anesthesiology, Pharmacology & Therapeutics at UBC.  Following his clinical training, he completed his Masters of Public Health in Quantitative Methods from the Harvard School of Public Health.  His clinical and academics areas of interest include patient safety in airway management and traumatic brain injury.

Dr. Bernard Riley

Dr Bernard Riley MBE BSc MBBS FRCA FFICM Bernard studied Microbiology at University College and Medicine at St George's Hospital, London, in preparation for a career as a Forensic Pathologist. He decided to switch to Intensive Care as he found trying to keep people alive was more rewarding than trying to find out why they died. After joining the Territorial Army he developed an interest in ballistic injury and chemical warfare and he was fortunate to be seconded to the British Army Trauma Life Support (BATLS) training cadre at the Royal Army Medical Corps HQ. He was appointed a consultant in Anaesthesia, Intensive Care and Pain Medicine in 1987 at St Stephens, The Westminster and Charing Cross Hospitals. In 1988 he was sponsored by the Prof of Military Surgery to become one of the first UK Advanced Trauma Life Support Instructors at the Royal College of Surgeons. He became the Anaesthesia/ICU rep on the ATLS Steering Group at the RCS and then its Chairman.

His last Regular Army service came in 1990-91 when after several years of suggesting that we should deploy senior doctors and an ICU facility as far forward as possible in the event of war he was a little taken aback to find he was tasked to set up such a unit in the field to provide a facility capable of mechanically ventilating victims of nerve gas poisoning. For a brief period of time 32 Field was the furthest forward unit in our part of the desert between the Iraqi army and a US forward Artillery unit - he wasn't sure which was the most worrying. He was awarded the MBE (Mil) for his operational work in the Gulf War and was decorated by H M Queen later that year.

On return to civilian practice he found life at the Westminster and the 125 Harley Street group practice a little mundane and wanted to concentrate more on trauma and neurosciences Intensive Care and was "head-hunted" to help set up a Trauma Centre at the Queen's Medical Centre in Nottingham in 1993. 20 years later it has just opened and he has just retired. Still in between there's been setting up the "Care of the Critically Ill Surgical Patient" programme at the RCS, Regional Advisership at the Royal College of Anaesthetists, Chairing various RCA committees, Head of the Nottingham and east Midlands School of Anaesthesia, Consultant Advisership to the Falkland Islands and a few other remaining "pink-bits" on the map. He has been awarded the Royal College of Anaesthetists Humphrey Davy Medal and Honorary Life Membership of the UK Intensive Care Society.

Bernard Riley - "A Change in Career" Story

2014 Presentation

Dr. Pierre Noel

Dr. Pierre Noel is a Professor of Medicine in the Mayo Clinic College of Medicine and serves as the Director of the Blood and Marrow Transplant Program in the Division of Hematology at Mayo. He joined Mayo in 1988 and left in 2000 to serve as the Chief of Hematology and a Senior Clinician for the National Institute of Health Clinical Center in Bethesda and a Consultant for the United States Homeland and National Security Council in Washington, DC. He rejoined Mayo in 2010 and has held a joint appointment in the Department of Laboratory Medicine/Pathology and the Division of Hematology since that time.

Dr. Noel received his M.D. degree and completed an internal medicine residency at the University of Sherbrook in Montreal, Canada. He completed a fellowship in hematology and was a foundation scholar at the Mayo Clinic College of Medicine in Rochester, Minnesota. Dr. Noel served as an officer in the military special operations community from 1997 through 2010 and is currently an advisor to the federal government on issues pertaining to medical support to counterterrorism operations.

Dr. Noel is the Chair of the Scientific Committee for the Board of Directors at Blood Systems; is a member of the Mayo Clinic Board of Governors Government Relations Committee; is the Vice Chair of Research for the Division of Hematology/Oncology; and is the Chair of the Military Medicine Initiative at Mayo Clinic in Arizona.

Dr. Noel developed the myeloid research core at the NIH Warren Magnuson Clinical Center Department of Medicine. The focus of the laboratory was eosinophil and mast cell disorders. He has 62 peer reviewed articles, 16 book chapters and 52 published abstracts related to his fields of interest.

2014 Presentation 1

2014 Presentation 2

Dr. James Russell

Dr. Russell is a Professor of Medicine at the University of British Columbia (UBC), a Principal Investigator in the Centre for Heart Lung Innovation, the Chief Medical Officer of the British Columbia Clinical Research Infrastructure Network (BCCRIN), and a member of the UBC and St. Paul’s Hospital (SPH) Divisions of Critical Care Medicine. BCCRIN is an organization dedicated to increasing the quality, quantity and funding of clinical research in BC. He has held a number of important leadership positions including Chair of Medicine, St. Paul’s Hospital (1993-2003).

Dr. Russell has over 180 peer-review publications and chapters and is on the Editorial Board of 4 journals. The two major current themes of his research are (1) the genomics and pharmacogenomics of septic shock and (2) vasopressin in septic shock. Dr. Russell worked with Sirius Genomics to design, implement, analyze, interpret and report the largest (over 11,000 patients) multicentre (US, Europe and Canada) case matched pharmacogenomics trial in Critical Care that aimed to validate pharmacogenomic biomarkers that identify septic patients who have an improved response to activated protein C (Xigris).

Dr. Russell has had an active research program focused on vasopressin treatment of septic shock. Leading the VASST trial, Dr. Russell found that vasopressin decreased mortality in patients who had less severe septic shock ((Russell JA, et al. N Engl J Med 2008; 358: 877 – 887) and discovered a novel interaction of vasopressin infusion, corticosteroid treatment and mortality of septic shock (Russell et al. Crit Care Med 37(3):811-818, 2009.) The VASST study is cited in the 2008 international sepsis treatment guidelines. Dr. Russell’s clinical research success in sepsis was recognized in an invited review in the New England Journal of Medicine (Russell JA. Management of sepsis. N Engl J Med 2006; 355 (16): 699 – 713.)

2014 Presentation